已收盘 11-06 16:00:00 美东时间
-5.280
-2.60%
最新财报显示,CRA国际2026财年第3季度实现: 营业收入:2.15亿美元 同比:增长15.61% 净利润:1390.6万美元 同比:增长21.21% 每股收...
11-08 19:00
CRA Intl (NASDAQ:CRAI) raises FY2026 sales outlook from $805.000 million-$820.000 million to $830.000 million-$840.000 million vs $814.338 million estimate.
11-05 21:39
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.19 per share which beat the analyst consensus estimate of $2.07 by 5.8 percent. This is a 6.31 percent increase over earnings of $2.06 per share from the same period last year. The company reported quarterly sales of $214.917 million which bea...
11-05 21:06
11月4日,CRA国际(CRAI)收跌0.97%,报195.26美元,成交额3171.17万美元,市值12.26亿美元。 行情数据 • 开盘价:196.51美元...
11-04 06:38
10月28日,CRA国际(CRAI)收跌3.62%,报194.3美元,成交额1941.13万美元,市值12.2亿美元。 行情数据 • 开盘价:201.41美元...
10-28 05:40
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-20 05:43
CRA Intl (NASDAQ:CRAI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. View...
10-09 21:51
CRA Intl (NASDAQ:CRAI) raises FY2026 sales outlook from $785.000 million-$805.000 million to $805.000 million-$820.000 million vs $801.210 million estimate.
08-06 20:14
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.16 per share which beat the analyst consensus estimate of $2.15 by 0.47 percent. This is a 14.89 percent increase over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $210.815 million which b...
08-06 20:11
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced that it has engaged Charles River Associates (CRA) (NASDAQ:CRAI) and Kaleio, Inc. to support co...
07-07 19:32